- Home
- WFRD vs ASND Comparison
WFRD vs ASND Comparison
Compare WFRD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- ASND
- Stock Information
- Founded
- WFRD 1941
- ASND 2006
- Country
- WFRD United States
- ASND Denmark
- Employees
- WFRD N/A
- ASND N/A
- Industry
- WFRD Metal Fabrications
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- WFRD Industrials
- ASND Health Care
- Exchange
- WFRD Nasdaq
- ASND Nasdaq
- Market Cap
- WFRD 7.9B
- ASND 7.7B
- IPO Year
- WFRD N/A
- ASND 2015
- Fundamental
- Price
- WFRD $79.03
- ASND $123.00
- Analyst Decision
- WFRD Strong Buy
- ASND Strong Buy
- Analyst Count
- WFRD 9
- ASND 13
- Target Price
- WFRD $146.00
- ASND $195.92
- AVG Volume (30 Days)
- WFRD 1.1M
- ASND 391.4K
- Earning Date
- WFRD 10-22-2024
- ASND 11-05-2024
- Dividend Yield
- WFRD 1.26%
- ASND N/A
- EPS Growth
- WFRD 51.37
- ASND N/A
- EPS
- WFRD 7.14
- ASND N/A
- Revenue
- WFRD $5,534,000,000.00
- ASND $340,327,869.00
- Revenue This Year
- WFRD $13.40
- ASND $16.12
- Revenue Next Year
- WFRD $7.20
- ASND $87.44
- P/E Ratio
- WFRD $11.09
- ASND N/A
- Revenue Growth
- WFRD 11.08
- ASND 166.54
- 52 Week Low
- WFRD $77.29
- ASND $86.55
- 52 Week High
- WFRD $135.00
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- WFRD 32.02
- ASND 39.09
- Support Level
- WFRD $77.29
- ASND $124.02
- Resistance Level
- WFRD $80.60
- ASND $133.97
- Average True Range (ATR)
- WFRD 3.06
- ASND 3.67
- MACD
- WFRD -0.76
- ASND -0.33
- Stochastic Oscillator
- WFRD 8.12
- ASND 15.18
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.